Slide 1: Q2 2024 Earnings Call
Q2 2024 EARNINGS CALL OFER HAVIV | PRESIDENT & CEO August 22, 2024
Slide 2: Forward-looking statements
This presentation contains "forward-looking statements" relating to future events, and Evogene Ltd. (the “Company”), may from time to time make other statements, regarding our outlook or expectations for future financial or operating results and/or other matters regarding or affecting us that are co
Slide 3: Agenda
Earnings Call Q2 2024 AGENDA Financial & Business highlights Evogene Overview Subsidiaries’ Achievements CFO Update / By Yaron Eldad Q&A 3 CEO Update / By Ofer Haviv Casterra Update / By Yoash Zohar
Slide 4: CEO Update: Q2 Financial highlights
4 4 CEO Update Q2 Financial highlights: In the first 6-month of 2024, total revenues reached approximately $5.1 million compared to $1.3 million in the first 6-month 2023. In full year 2024, anticipated continued revenue growth compared to the previous year, mainly upon Casterra’s starting of supply
Slide 5: Q2 Business Highlights
Q2 Business Highlights: Casterra Received an additional $440K purchase order to supply castor seeds to a new African country Successfully completed its castor seed growing and harvesting season in Brazil with shipments planned for Q3 2024. The company anticipates that the seeds produced in Brazil an
Slide 6: Agenda: Evogene Overview
Earnings Call Q2 2024 AGENDA Financial & Business highlights Evogene Overview Subsidiaries’ Achievements CFO Update / By Yaron Eldad Q&A 6 CEO Update / By Ofer Haviv Casterra Update / By Yoash Zohar
Slide 7: Our Vision
OUR VISION PIONEER GROUNDBREAKING LIFE-SCIENCE PRODUCTS ROOTED IN MICROBES, SMALL MOLECULES, AND GENOMICS DECODING BIOLOGY 7
Slide 8: Discovery & Optimization with 3 AI tech-engines
DISCOVERY & OPTIMIZATION WE DIRECT AND ACCELERATE LIFE-SCIENCE PRODUCT through 3 dedicated AI tech-engines MICROBES GENETIC ELEMENTS SMALL MOLECULES The Result: Promising candidates addressing multiple development challenges towards successful life-science-based products. PROBABILITY OF SUCCESS TIME
Slide 9: A World of Opportunities for Our AI Tech Engines
9 SMALL MOLECULES GENETIC ELEMENTS MICROBES A WORLD OF OPPORTUNITIES FOR OUR AI TECH ENGINES AGRICULTURE & FOOD PHARMA & WELLNESS OTHER INDUSTRIES Improvedcrops Alternativefood Medical Cannabis Genetherapy Diagnostics & precisionmedicine Celltherapy Bio fuel Fragrances Natural foodcoloring Novelenzy
Slide 10: Business Strategy
10 BUSINESS STRATEGY Capture the value of our AI tech-engines through diverse collaborative partnerships to accelerate life-science product development Partnering with experts in specific fields complements our technology, enabling groundbreaking innovations and financial gains for Evogene. EVOGENE
Slide 11: Licensing & Collaboration | Current Status
Aquaculture Licensing Collaboration Improved crops Crop protection Pharmaceuticals Microbials for crops Therapeutic microbials 11 LICENSING & COLLABORATION | CURRENT STATUS Food-Tech AGRICULTURE & FOOD PHARMA & WELLNESS OTHER INDUSTRIES AGRICULTURE & FOOD PHARMA & WELLNESS OTHER INDUSTRIES AGRICULTU
Slide 12: Commercial & Financial Partners
12 Group COMMERCIAL & FINANCIAL PARTNERS Investment & Collaboration Collaboration Investment & Collaboration Collaboration Collaboration Investment Collaboration Collaboration Collaboration Collaboration Collaboration
Slide 13: Agenda: Subsidiaries' Achievements
Earnings Call Q2 2024 AGENDA Financial & Business highlights Evogene Overview Subsidiaries’ Achievements CFO Update / By Yaron Eldad Q&A 13 CEO Update / By Ofer Haviv Casterra Update / By Yoash Zohar
Slide 14: Casterra update
14 Casterra, Evogene’s fully owned subsidiary, focuses on developing integrated solutions for large-scale castor bean cultivation, utilizing GeneRator AI tech-engine. June 25 - Received an additional $440K purchase order to supply castor seeds to a new African country. July 31 - Successfully complet
Slide 15: Lavie Bio update
15 Lavie Bio, a global leader in developing next generation ag-biological products, leveraging MicroBoost AI tech-engine July 2 - Lavie Bio announced the commercial expansion of its bio-inoculant product, Yalos™, to winter wheat following successful trials, with sales commencing across the US for th
Slide 16: Biomica update
16 Biomica specializes in developing microbiome-based therapeutics for human health, utilizing Evogene's MicroBoost AI tech-engine May 23 – Exceptional safety and tolerability data for BMC128 was published. 72% of the patients treated have exhibited clinical benefits. 55% of patients showed sustaine
Slide 17: Agenda: Casterra Update
Earnings Call Q2 2024 AGENDA Financial & Business highlights Evogene Overview Subsidiaries’ Achievements CFO Update / By Yaron Eldad Q&A 17 CEO Update / By Ofer Haviv Casterra Update / By Yoash Zohar
Slide 18: Our Vision and Mission
18 OUR VISION Position Casterra as a major provider of sustainable plant oil as feedstock for the global biobased industries with emphasis on biofuel. OUR MISSION To provide an integrated ag-solution based on elite seed varieties for industrial scale cultivation of castor for the biobased industries
Slide 19: Castor Oil Value Chain and Uses
Castor Oil Value Chain and Uses 19 Oil Industrial application derivatives (~85%**) ‘Cake’* Fertilizer and nematodes suppressor (~15%**) Castor grain crusher * Castor cake is nitrogen-rich organic fertilizer, obtained as a solid residue from the treatment of seeds for castor oil ** Percentage of valu
Slide 20: The Challenge
The Challenge 20 Family size farms Tall shrub hand-picked Traditional cultivation Low yield (0.6 MT/Ha.) Perennial plant Most of the global castor supply is from India where castor is grown in traditional methods and the harvesting is done manually. This cannot support the increased demand for casto
Slide 21: Our Solution
Our Solution 21 Casterra has established a unique integrated ag-solution, which includes proprietary castor seed varieties, supported by agro-technical know-how and novel mechanized harvesting & dehulling, addressing the global demand for increased and stable castor oil supply. Low yield, tall shrub
Slide 22: In a Nutshell
22 In a Nutshell CASTOR OIL - EMERGING MARKET INTEGRATED AG-SOLUTION COMMERCIAL PRODUCTS Proprietary varieties with improved traits suitable for commercial scale cultivation EVF716, EVF712, EVF701 Elite varieties suitable for mechanized farming, growing protocols, mechanized harvesting and dehulling
Slide 23: 2023 Seed Orders
23 $9.1 Million $2.2 Million 2023 Seed Orders
Slide 24: 2024 Seed Order & Production Expansion
24 ~$440K Production of approximately 500 tons 2024 Seed Order & Production Expansion
Slide 25: Seed Production Operation, Aug. 2024
Seed Production Operation, Aug. 2024 25 Over 130 tons of our high-quality castor seeds ready for shipment from one of our seed growers in Brazil, supporting our customers mainly in Africa Casterra completed a successful castor seed harvest in Brazil with shipments planned for Q3 2024 and began the h
Slide 26: Potential Next Stage
Exploring economic implications of expanding to castor oil production Potential partnership: Casterra - grain production Established oil producer Bio-based industries Biofuel 26 Potential Next Stage
Slide 27: Agenda: CFO Update
Earnings Call Q2 2024 AGENDA Financial & Business highlights Evogene Overview Subsidiaries’ Achievements CFO Update / By Yaron Eldad Q&A 27 CEO Update / By Ofer Haviv Casterra Update / By Yoash Zohar
Slide 28: Balance sheet
CURRENT ASSETS: F Pp DATE Cashand cash equivalents Short-term ban: deposits ‘Trade receivables Other ceceivables and prepaid expanses Inventodes LONG-TERM ASSETS: Long-temn deposits and other ceccivables [Investment accounted for using the equity method Rightofuse-assets Broperty, slant and equipmen
Slide 29: CFO Update: Evogene Financial Performance Q2 2024
CFO UPDATE Evogene Financial Performance Q2 2024 29
Slide 30: Agenda: Q&A
Earnings Call Q2 2024 AGENDA Financial & Business highlights Evogene Overview Subsidiaries’ Achievements CFO Update / By Yaron Eldad Q&A 30 CEO Update / By Ofer Haviv
Slide 31: Thank You
THANK YOU